Further, deregulation of epithelial-mesenchymal transition (EMT) and neural invasion via NF-kB inhibition in pancreatic cancer delineates the possibility of targeting NF-kB in PDAC [33]. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.